About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Psoriasis Patients Using Immunosuppressants Survive COVID-19

by Angela Mohan on October 21, 2020 at 3:25 PM
Font : A-A+

Psoriasis Patients Using Immunosuppressants Survive COVID-19

Psoriasis patients using immunosuppressant drugs have good COVID-19 survive rates, says a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians.

The researchers found that the risk factors of severe COVID-19 outcomes in patients reported to the registry were similar to the general population.

Advertisement


The findings come from the first analysis of the web-based PsoProtect registry, established to understand how psoriasis and the medications that are used to treat it might influence the severity of COVID-19.

Collaboration has been crucial to the registry, founded by dermatologists and researchers at the St John's Institute of Dermatology at Guy's and St Thomas', King's College London and University of Manchester, and supported by psoriasis patient organizations throughout the world, including the Psoriasis Association in the UK.
Advertisement

Psoriasis is a skin condition that causes red, flaky, crusty plaques of skin covered with silvery scales and affects around 2% of people in the UK. It is thought to be related to a problem in the immune system, so dermatologists have been working to understand how COVID-19 and the condition may interact.

Patients with moderate to severe disease are treated with drugs that affect the immune system including biologics that target specific immune proteins, or traditional tablet immunosuppressants, and many of these patients were asked to shield during the pandemic.

Dr Satveer Mahil, a consultant dermatologist at the St John's Institute of Dermatology at Guy's and St Thomas', co-leads the registry. She said: "Our analysis is important for informing our conversations with patients as the pandemic continues. We can reassure our patients that the survival for people with psoriasis is high, and the risk factors for psoriasis patients are similar to those of the general population.

"These findings wouldn't be possible without all the clinicians who have reported cases to PsoProtect and the invaluable support of our partner professional and patient organizations."

Helen McAteer, Chief Executive of the Psoriasis Association said: "From the beginning of the pandemic we understood the importance of being proactive in order to address many concerns expressed by people who are living with psoriasis.

The PsoProtect registry is vital in helping us understand more about the interactions between psoriasis, its treatments and COVID-19 infection so as patients can make the most informed choices about their care and treatment at this challenging time."

The initial findings from the PsoProtect registry were published in the Journal of Allergy and Clinical Immunology. The paper is an analysis of 374 clinician-reported cases where patients with psoriasis had COVID-19. The cases came from 25 countries, and were submitted between March and July 2020. Most of the patients (334, 89%) were taking biologics for their psoriasis (267, 71%) or traditional immunosuppressants (67, 18%).

Most of the cases - 348 (93%) fully recovered from COVID-19, 77 (21%) were hospitalized and nine (2%) died. The study found that, similarly to the general population, patients who were older, male, of non-white ethnicity and with other health conditions such as chronic lung disease were more likely to require hospital admission for their COVID-19 infection.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
Drinking This Popular Beverage May Drop Dementia Risk
Worst Mistakes Parents Make When Talking to Kids
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Psoriasis Aplastic Anemia Dry Skin Symptom Evaluation Foods that are Bad for your Skin Itchy Scalp Diet for Psoriasis Scalp Psoriasis Psoriasis Cure with Homeopathy: Fact or Fiction Psoriatic Arthritis Coronavirus 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Noscaphene (Noscapine) Loram (2 mg) (Lorazepam) Calculate Ideal Weight for Infants How to Reduce School Bag Weight - Simple Tips A-Z Drug Brands in India Blood Pressure Calculator Sinopril (2mg) (Lacidipine) Blood Donation - Recipients Accident and Trauma Care

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use